Pharma & Healthcare
Global Swine Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301269
- Pages: 162
- Figures: 161
- Views: 34
In 2024, the global market size of Swine Vaccines was estimated to be worth US$ 1491 million and is forecast to reach approximately US$ 1954 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Segment by Application
Government Tender
Market Sales
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Swine Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Segment by Application
Government Tender
Market Sales
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Swine Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Swine Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Swine Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Swine Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Swine Vaccines Market Size Estimates and Forecasts
2.1.1 Global Swine Vaccines Revenue 2020-2031
2.1.2 Global Swine Vaccines Sales 2020-2031
2.2 Swine Vaccines Market Size by Region: 2024 Versus 2031
2.3 Swine Vaccines Sales by Region (2020-2031)
2.3.1 Global Swine Vaccines Sales by Region: 2020-2025
2.3.2 Global Swine Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Swine Vaccines Sales Market Share by Region (2020-2031)
2.4 Swine Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Swine Vaccines Revenue by Region: 2020-2025
2.4.2 Global Swine Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Swine Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Swine Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Swine Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Swine Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Swine Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Swine Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Swine Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Swine Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Swine Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Swine Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Swine Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Swine Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Swine Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Swine Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Swine Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 CSF Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.2 FMD Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.3 Porcine Circovirus Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.4 PRRS Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.5 Others of Swine Vaccines Revenue Market Share by Application
4 Global Swine Vaccines by Manufacturers
4.1 Global Top Swine Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Swine Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Swine Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Swine Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Swine Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Swine Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Swine Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Swine Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Swine Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Swine Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Swine Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Swine Vaccines Market
4.5.3 Manufacturers Swine Vaccines Product Type and Application
4.5.4 CSF Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.5 FMD Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.6 Porcine Circovirus Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.7 PRRS Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.8 Others Market Sales of Swine Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Swine Vaccines Products Offered
5.1.4 Merck Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Swine Vaccines Sales by Product in 2024
5.1.6 Merck Swine Vaccines Sales by Application in 2024
5.1.7 Merck Swine Vaccines Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Company Information
5.2.2 Boehringer Ingelheim Description, Business Overview
5.2.3 Boehringer Ingelheim Swine Vaccines Products Offered
5.2.4 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Boehringer Ingelheim Swine Vaccines Sales by Product in 2024
5.2.6 Boehringer Ingelheim Swine Vaccines Sales by Application in 2024
5.2.7 Boehringer Ingelheim Swine Vaccines Sales by Geographic Area in 2024
5.2.8 Boehringer Ingelheim Recent Developments
5.3 Jinyu Bio-Technology
5.3.1 Jinyu Bio-Technology Company Information
5.3.2 Jinyu Bio-Technology Description, Business Overview
5.3.3 Jinyu Bio-Technology Swine Vaccines Products Offered
5.3.4 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Jinyu Bio-Technology Swine Vaccines Sales by Product in 2024
5.3.6 Jinyu Bio-Technology Swine Vaccines Sales by Application in 2024
5.3.7 Jinyu Bio-Technology Swine Vaccines Sales by Geographic Area in 2024
5.3.8 Jinyu Bio-Technology Recent Developments
5.4 CAHIC
5.4.1 CAHIC Company Information
5.4.2 CAHIC Description, Business Overview
5.4.3 CAHIC Swine Vaccines Products Offered
5.4.4 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 CAHIC Swine Vaccines Sales by Product in 2024
5.4.6 CAHIC Swine Vaccines Sales by Application in 2024
5.4.7 CAHIC Swine Vaccines Sales by Geographic Area in 2024
5.4.8 CAHIC Recent Developments
5.5 Tecon
5.5.1 Tecon Company Information
5.5.2 Tecon Description, Business Overview
5.5.3 Tecon Swine Vaccines Products Offered
5.5.4 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Tecon Swine Vaccines Sales by Product in 2024
5.5.6 Tecon Swine Vaccines Sales by Application in 2024
5.5.7 Tecon Swine Vaccines Sales by Geographic Area in 2024
5.5.8 Tecon Recent Developments
5.6 Zoetis
5.6.1 Zoetis Company Information
5.6.2 Zoetis Description, Business Overview
5.6.3 Zoetis Swine Vaccines Products Offered
5.6.4 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Zoetis Swine Vaccines Sales by Product in 2024
5.6.6 Zoetis Swine Vaccines Sales by Application in 2024
5.6.7 Zoetis Swine Vaccines Sales by Geographic Area in 2024
5.6.8 Zoetis Recent Developments
5.7 Ceva
5.7.1 Ceva Company Information
5.7.2 Ceva Description, Business Overview
5.7.3 Ceva Swine Vaccines Products Offered
5.7.4 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Ceva Swine Vaccines Sales by Product in 2024
5.7.6 Ceva Swine Vaccines Sales by Application in 2024
5.7.7 Ceva Swine Vaccines Sales by Geographic Area in 2024
5.7.8 Ceva Recent Developments
5.8 Hile Bio
5.8.1 Hile Bio Company Information
5.8.2 Hile Bio Description, Business Overview
5.8.3 Hile Bio Swine Vaccines Products Offered
5.8.4 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Hile Bio Swine Vaccines Sales by Product in 2024
5.8.6 Hile Bio Swine Vaccines Sales by Application in 2024
5.8.7 Hile Bio Swine Vaccines Sales by Geographic Area in 2024
5.8.8 Hile Bio Recent Developments
5.9 Chopper Biology
5.9.1 Chopper Biology Company Information
5.9.2 Chopper Biology Description, Business Overview
5.9.3 Chopper Biology Swine Vaccines Products Offered
5.9.4 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Chopper Biology Swine Vaccines Sales by Product in 2024
5.9.6 Chopper Biology Swine Vaccines Sales by Application in 2024
5.9.7 Chopper Biology Swine Vaccines Sales by Geographic Area in 2024
5.9.8 Chopper Biology Recent Developments
5.10 WINSUN
5.10.1 WINSUN Company Information
5.10.2 WINSUN Description, Business Overview
5.10.3 WINSUN Swine Vaccines Products Offered
5.10.4 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 WINSUN Swine Vaccines Sales by Product in 2024
5.10.6 WINSUN Swine Vaccines Sales by Application in 2024
5.10.7 WINSUN Swine Vaccines Sales by Geographic Area in 2024
5.10.8 WINSUN Recent Developments
5.11 Hipra
5.11.1 Hipra Company Information
5.11.2 Hipra Description, Business Overview
5.11.3 Hipra Swine Vaccines Products Offered
5.11.4 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Hipra Swine Vaccines Sales by Product in 2024
5.11.6 Hipra Swine Vaccines Sales by Application in 2024
5.11.7 Hipra Swine Vaccines Sales by Geographic Area in 2024
5.11.8 Hipra Recent Developments
5.12 Ringpu Biology
5.12.1 Ringpu Biology Company Information
5.12.2 Ringpu Biology Description, Business Overview
5.12.3 Ringpu Biology Swine Vaccines Products Offered
5.12.4 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Ringpu Biology Swine Vaccines Sales by Product in 2024
5.12.6 Ringpu Biology Swine Vaccines Sales by Application in 2024
5.12.7 Ringpu Biology Swine Vaccines Sales by Geographic Area in 2024
5.12.8 Ringpu Biology Recent Developments
5.13 ChengDu Tecbond
5.13.1 ChengDu Tecbond Company Information
5.13.2 ChengDu Tecbond Description, Business Overview
5.13.3 ChengDu Tecbond Swine Vaccines Products Offered
5.13.4 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 ChengDu Tecbond Swine Vaccines Sales by Product in 2024
5.13.6 ChengDu Tecbond Swine Vaccines Sales by Application in 2024
5.13.7 ChengDu Tecbond Swine Vaccines Sales by Geographic Area in 2024
5.13.8 ChengDu Tecbond Recent Developments
5.14 DHN
5.14.1 DHN Company Information
5.14.2 DHN Description, Business Overview
5.14.3 DHN Swine Vaccines Products Offered
5.14.4 DHN Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 DHN Swine Vaccines Sales by Product in 2024
5.14.6 DHN Swine Vaccines Sales by Application in 2024
5.14.7 DHN Swine Vaccines Sales by Geographic Area in 2024
5.14.8 DHN Recent Developments
5.15 CAVAC
5.15.1 CAVAC Company Information
5.15.2 CAVAC Description, Business Overview
5.15.3 CAVAC Swine Vaccines Products Offered
5.15.4 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.15.5 CAVAC Swine Vaccines Sales by Product in 2024
5.15.6 CAVAC Swine Vaccines Sales by Application in 2024
5.15.7 CAVAC Swine Vaccines Sales by Geographic Area in 2024
5.15.8 CAVAC Recent Developments
5.16 Virbac
5.16.1 Virbac Company Information
5.16.2 Virbac Description, Business Overview
5.16.3 Virbac Swine Vaccines Products Offered
5.16.4 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Virbac Swine Vaccines Sales by Product in 2024
5.16.6 Virbac Swine Vaccines Sales by Application in 2024
5.16.7 Virbac Swine Vaccines Sales by Geographic Area in 2024
5.16.8 Virbac Recent Developments
5.17 HVRI
5.17.1 HVRI Company Information
5.17.2 HVRI Description, Business Overview
5.17.3 HVRI Swine Vaccines Products Offered
5.17.4 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.17.5 HVRI Swine Vaccines Sales by Product in 2024
5.17.6 HVRI Swine Vaccines Sales by Application in 2024
5.17.7 HVRI Swine Vaccines Sales by Geographic Area in 2024
5.17.8 HVRI Recent Developments
5.18 Bioveta
5.18.1 Bioveta Company Information
5.18.2 Bioveta Description, Business Overview
5.18.3 Bioveta Swine Vaccines Products Offered
5.18.4 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Bioveta Swine Vaccines Sales by Product in 2024
5.18.6 Bioveta Swine Vaccines Sales by Application in 2024
5.18.7 Bioveta Swine Vaccines Sales by Geographic Area in 2024
5.18.8 Bioveta Recent Developments
6 North America
6.1 North America Swine Vaccines Market Size YoY Growth 2020-2031
6.2 North America Swine Vaccines Market Facts & Figures by Country
6.2.1 North America Swine Vaccines Sales by Country (2020-2031)
6.2.2 North America Swine Vaccines Revenue by Country (2020-2031)
6.3 North America Swine Vaccines Sales by Type (2020-2025)
6.4 North America Swine Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Swine Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Swine Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Swine Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Swine Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Swine Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Swine Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Swine Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Swine Vaccines Market Facts & Figures by Country
8.2.1 Europe Swine Vaccines Sales by Country (2020-2031)
8.2.2 Europe Swine Vaccines Revenue by Country (2020-2031)
8.3 Europe Swine Vaccines Sales by Type (2020-2025)
8.4 Europe Swine Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Swine Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Swine Vaccines Market Facts & Figures by Country
9.2.1 Latin America Swine Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Swine Vaccines Revenue by Country (2020-2031)
9.3 Latin America Swine Vaccines Sales by Type (2020-2025)
9.4 Latin America Swine Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Swine Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Swine Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Swine Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Swine Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Swine Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Swine Vaccines Supply Chain Analysis
11.2 Swine Vaccines Key Raw Materials and Upstream Suppliers
11.3 Swine Vaccines Clients Analysis
11.4 Swine Vaccines Sales Channel and Sales Model Analysis
11.4.1 Swine Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Swine Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Swine Vaccines Distributors
12 Swine Vaccines Market Dynamics
12.1 Swine Vaccines Industry Trends
12.2 Swine Vaccines Market Drivers
12.3 Swine Vaccines Market Challenges
12.4 Swine Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Swine Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Swine Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Swine Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Swine Vaccines Market Size Estimates and Forecasts
2.1.1 Global Swine Vaccines Revenue 2020-2031
2.1.2 Global Swine Vaccines Sales 2020-2031
2.2 Swine Vaccines Market Size by Region: 2024 Versus 2031
2.3 Swine Vaccines Sales by Region (2020-2031)
2.3.1 Global Swine Vaccines Sales by Region: 2020-2025
2.3.2 Global Swine Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Swine Vaccines Sales Market Share by Region (2020-2031)
2.4 Swine Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Swine Vaccines Revenue by Region: 2020-2025
2.4.2 Global Swine Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Swine Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Swine Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Swine Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Swine Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Swine Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Swine Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Swine Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Swine Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Swine Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Swine Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Swine Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Swine Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Swine Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Swine Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Swine Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 CSF Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.2 FMD Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.3 Porcine Circovirus Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.4 PRRS Vaccines of Swine Vaccines Revenue Market Share by Application
3.3.5 Others of Swine Vaccines Revenue Market Share by Application
4 Global Swine Vaccines by Manufacturers
4.1 Global Top Swine Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Swine Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Swine Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Swine Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Swine Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Swine Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Swine Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Swine Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Swine Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Swine Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Swine Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Swine Vaccines Market
4.5.3 Manufacturers Swine Vaccines Product Type and Application
4.5.4 CSF Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.5 FMD Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.6 Porcine Circovirus Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.7 PRRS Vaccines Market Sales of Swine Vaccines by Manufacturer
4.5.8 Others Market Sales of Swine Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Swine Vaccines Products Offered
5.1.4 Merck Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Swine Vaccines Sales by Product in 2024
5.1.6 Merck Swine Vaccines Sales by Application in 2024
5.1.7 Merck Swine Vaccines Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Company Information
5.2.2 Boehringer Ingelheim Description, Business Overview
5.2.3 Boehringer Ingelheim Swine Vaccines Products Offered
5.2.4 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Boehringer Ingelheim Swine Vaccines Sales by Product in 2024
5.2.6 Boehringer Ingelheim Swine Vaccines Sales by Application in 2024
5.2.7 Boehringer Ingelheim Swine Vaccines Sales by Geographic Area in 2024
5.2.8 Boehringer Ingelheim Recent Developments
5.3 Jinyu Bio-Technology
5.3.1 Jinyu Bio-Technology Company Information
5.3.2 Jinyu Bio-Technology Description, Business Overview
5.3.3 Jinyu Bio-Technology Swine Vaccines Products Offered
5.3.4 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Jinyu Bio-Technology Swine Vaccines Sales by Product in 2024
5.3.6 Jinyu Bio-Technology Swine Vaccines Sales by Application in 2024
5.3.7 Jinyu Bio-Technology Swine Vaccines Sales by Geographic Area in 2024
5.3.8 Jinyu Bio-Technology Recent Developments
5.4 CAHIC
5.4.1 CAHIC Company Information
5.4.2 CAHIC Description, Business Overview
5.4.3 CAHIC Swine Vaccines Products Offered
5.4.4 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 CAHIC Swine Vaccines Sales by Product in 2024
5.4.6 CAHIC Swine Vaccines Sales by Application in 2024
5.4.7 CAHIC Swine Vaccines Sales by Geographic Area in 2024
5.4.8 CAHIC Recent Developments
5.5 Tecon
5.5.1 Tecon Company Information
5.5.2 Tecon Description, Business Overview
5.5.3 Tecon Swine Vaccines Products Offered
5.5.4 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Tecon Swine Vaccines Sales by Product in 2024
5.5.6 Tecon Swine Vaccines Sales by Application in 2024
5.5.7 Tecon Swine Vaccines Sales by Geographic Area in 2024
5.5.8 Tecon Recent Developments
5.6 Zoetis
5.6.1 Zoetis Company Information
5.6.2 Zoetis Description, Business Overview
5.6.3 Zoetis Swine Vaccines Products Offered
5.6.4 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Zoetis Swine Vaccines Sales by Product in 2024
5.6.6 Zoetis Swine Vaccines Sales by Application in 2024
5.6.7 Zoetis Swine Vaccines Sales by Geographic Area in 2024
5.6.8 Zoetis Recent Developments
5.7 Ceva
5.7.1 Ceva Company Information
5.7.2 Ceva Description, Business Overview
5.7.3 Ceva Swine Vaccines Products Offered
5.7.4 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Ceva Swine Vaccines Sales by Product in 2024
5.7.6 Ceva Swine Vaccines Sales by Application in 2024
5.7.7 Ceva Swine Vaccines Sales by Geographic Area in 2024
5.7.8 Ceva Recent Developments
5.8 Hile Bio
5.8.1 Hile Bio Company Information
5.8.2 Hile Bio Description, Business Overview
5.8.3 Hile Bio Swine Vaccines Products Offered
5.8.4 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Hile Bio Swine Vaccines Sales by Product in 2024
5.8.6 Hile Bio Swine Vaccines Sales by Application in 2024
5.8.7 Hile Bio Swine Vaccines Sales by Geographic Area in 2024
5.8.8 Hile Bio Recent Developments
5.9 Chopper Biology
5.9.1 Chopper Biology Company Information
5.9.2 Chopper Biology Description, Business Overview
5.9.3 Chopper Biology Swine Vaccines Products Offered
5.9.4 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Chopper Biology Swine Vaccines Sales by Product in 2024
5.9.6 Chopper Biology Swine Vaccines Sales by Application in 2024
5.9.7 Chopper Biology Swine Vaccines Sales by Geographic Area in 2024
5.9.8 Chopper Biology Recent Developments
5.10 WINSUN
5.10.1 WINSUN Company Information
5.10.2 WINSUN Description, Business Overview
5.10.3 WINSUN Swine Vaccines Products Offered
5.10.4 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 WINSUN Swine Vaccines Sales by Product in 2024
5.10.6 WINSUN Swine Vaccines Sales by Application in 2024
5.10.7 WINSUN Swine Vaccines Sales by Geographic Area in 2024
5.10.8 WINSUN Recent Developments
5.11 Hipra
5.11.1 Hipra Company Information
5.11.2 Hipra Description, Business Overview
5.11.3 Hipra Swine Vaccines Products Offered
5.11.4 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Hipra Swine Vaccines Sales by Product in 2024
5.11.6 Hipra Swine Vaccines Sales by Application in 2024
5.11.7 Hipra Swine Vaccines Sales by Geographic Area in 2024
5.11.8 Hipra Recent Developments
5.12 Ringpu Biology
5.12.1 Ringpu Biology Company Information
5.12.2 Ringpu Biology Description, Business Overview
5.12.3 Ringpu Biology Swine Vaccines Products Offered
5.12.4 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Ringpu Biology Swine Vaccines Sales by Product in 2024
5.12.6 Ringpu Biology Swine Vaccines Sales by Application in 2024
5.12.7 Ringpu Biology Swine Vaccines Sales by Geographic Area in 2024
5.12.8 Ringpu Biology Recent Developments
5.13 ChengDu Tecbond
5.13.1 ChengDu Tecbond Company Information
5.13.2 ChengDu Tecbond Description, Business Overview
5.13.3 ChengDu Tecbond Swine Vaccines Products Offered
5.13.4 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 ChengDu Tecbond Swine Vaccines Sales by Product in 2024
5.13.6 ChengDu Tecbond Swine Vaccines Sales by Application in 2024
5.13.7 ChengDu Tecbond Swine Vaccines Sales by Geographic Area in 2024
5.13.8 ChengDu Tecbond Recent Developments
5.14 DHN
5.14.1 DHN Company Information
5.14.2 DHN Description, Business Overview
5.14.3 DHN Swine Vaccines Products Offered
5.14.4 DHN Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 DHN Swine Vaccines Sales by Product in 2024
5.14.6 DHN Swine Vaccines Sales by Application in 2024
5.14.7 DHN Swine Vaccines Sales by Geographic Area in 2024
5.14.8 DHN Recent Developments
5.15 CAVAC
5.15.1 CAVAC Company Information
5.15.2 CAVAC Description, Business Overview
5.15.3 CAVAC Swine Vaccines Products Offered
5.15.4 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.15.5 CAVAC Swine Vaccines Sales by Product in 2024
5.15.6 CAVAC Swine Vaccines Sales by Application in 2024
5.15.7 CAVAC Swine Vaccines Sales by Geographic Area in 2024
5.15.8 CAVAC Recent Developments
5.16 Virbac
5.16.1 Virbac Company Information
5.16.2 Virbac Description, Business Overview
5.16.3 Virbac Swine Vaccines Products Offered
5.16.4 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Virbac Swine Vaccines Sales by Product in 2024
5.16.6 Virbac Swine Vaccines Sales by Application in 2024
5.16.7 Virbac Swine Vaccines Sales by Geographic Area in 2024
5.16.8 Virbac Recent Developments
5.17 HVRI
5.17.1 HVRI Company Information
5.17.2 HVRI Description, Business Overview
5.17.3 HVRI Swine Vaccines Products Offered
5.17.4 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.17.5 HVRI Swine Vaccines Sales by Product in 2024
5.17.6 HVRI Swine Vaccines Sales by Application in 2024
5.17.7 HVRI Swine Vaccines Sales by Geographic Area in 2024
5.17.8 HVRI Recent Developments
5.18 Bioveta
5.18.1 Bioveta Company Information
5.18.2 Bioveta Description, Business Overview
5.18.3 Bioveta Swine Vaccines Products Offered
5.18.4 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Bioveta Swine Vaccines Sales by Product in 2024
5.18.6 Bioveta Swine Vaccines Sales by Application in 2024
5.18.7 Bioveta Swine Vaccines Sales by Geographic Area in 2024
5.18.8 Bioveta Recent Developments
6 North America
6.1 North America Swine Vaccines Market Size YoY Growth 2020-2031
6.2 North America Swine Vaccines Market Facts & Figures by Country
6.2.1 North America Swine Vaccines Sales by Country (2020-2031)
6.2.2 North America Swine Vaccines Revenue by Country (2020-2031)
6.3 North America Swine Vaccines Sales by Type (2020-2025)
6.4 North America Swine Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Swine Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Swine Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Swine Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Swine Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Swine Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Swine Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Swine Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Swine Vaccines Market Facts & Figures by Country
8.2.1 Europe Swine Vaccines Sales by Country (2020-2031)
8.2.2 Europe Swine Vaccines Revenue by Country (2020-2031)
8.3 Europe Swine Vaccines Sales by Type (2020-2025)
8.4 Europe Swine Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Swine Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Swine Vaccines Market Facts & Figures by Country
9.2.1 Latin America Swine Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Swine Vaccines Revenue by Country (2020-2031)
9.3 Latin America Swine Vaccines Sales by Type (2020-2025)
9.4 Latin America Swine Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Swine Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Swine Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Swine Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Swine Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Swine Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Swine Vaccines Supply Chain Analysis
11.2 Swine Vaccines Key Raw Materials and Upstream Suppliers
11.3 Swine Vaccines Clients Analysis
11.4 Swine Vaccines Sales Channel and Sales Model Analysis
11.4.1 Swine Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Swine Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Swine Vaccines Distributors
12 Swine Vaccines Market Dynamics
12.1 Swine Vaccines Industry Trends
12.2 Swine Vaccines Market Drivers
12.3 Swine Vaccines Market Challenges
12.4 Swine Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Swine Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Swine Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Swine Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Swine Vaccines Sales by Region (2020-2025) & (M Doses)
Table 5. Global Swine Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Swine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Swine Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Swine Vaccines Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Swine Vaccines Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Swine Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Swine Vaccines Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Swine Vaccines Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Swine Vaccines Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Swine Vaccines Sales Share by Manufacturer (2020-2025)
Table 18. Swine Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Swine Vaccines Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Swine Vaccines Price (2020-2025) & (USD/K Doses)
Table 21. Ranking of Global Top Swine Vaccines Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Swine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Swine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Vaccines as of 2024)
Table 24. Swine Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Swine Vaccines Market
Table 26. Manufacturers Swine Vaccines Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Merck Company Information
Table 29. Merck Description and Business Overview
Table 30. Merck Swine Vaccines Product
Table 31. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 32. Merck Sales Proportion of Swine Vaccines by Product in 2024
Table 33. Merck Sales Proportion of Swine Vaccines by Application in 2024
Table 34. Merck Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 35. Merck Recent Developments
Table 36. Boehringer Ingelheim Company Information
Table 37. Boehringer Ingelheim Description and Business Overview
Table 38. Boehringer Ingelheim Swine Vaccines Product
Table 39. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 40. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Product in 2024
Table 41. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Application in 2024
Table 42. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 43. Boehringer Ingelheim Recent Developments
Table 44. Jinyu Bio-Technology Company Information
Table 45. Jinyu Bio-Technology Description and Business Overview
Table 46. Jinyu Bio-Technology Swine Vaccines Product
Table 47. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 48. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Product in 2024
Table 49. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Application in 2024
Table 50. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 51. Jinyu Bio-Technology Recent Developments
Table 52. CAHIC Company Information
Table 53. CAHIC Description and Business Overview
Table 54. CAHIC Swine Vaccines Product
Table 55. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 56. CAHIC Sales Proportion of Swine Vaccines by Product in 2024
Table 57. CAHIC Sales Proportion of Swine Vaccines by Application in 2024
Table 58. CAHIC Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 59. CAHIC Recent Developments
Table 60. Tecon Company Information
Table 61. Tecon Description and Business Overview
Table 62. Tecon Swine Vaccines Product
Table 63. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 64. Tecon Sales Proportion of Swine Vaccines by Product in 2024
Table 65. Tecon Sales Proportion of Swine Vaccines by Application in 2024
Table 66. Tecon Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 67. Tecon Recent Developments
Table 68. Zoetis Company Information
Table 69. Zoetis Description and Business Overview
Table 70. Zoetis Swine Vaccines Product
Table 71. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 72. Zoetis Sales Proportion of Swine Vaccines by Product in 2024
Table 73. Zoetis Sales Proportion of Swine Vaccines by Application in 2024
Table 74. Zoetis Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 75. Zoetis Recent Developments
Table 76. Ceva Company Information
Table 77. Ceva Description and Business Overview
Table 78. Ceva Swine Vaccines Product
Table 79. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Ceva Sales Proportion of Swine Vaccines by Product in 2024
Table 81. Ceva Sales Proportion of Swine Vaccines by Application in 2024
Table 82. Ceva Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 83. Ceva Recent Developments
Table 84. Hile Bio Company Information
Table 85. Hile Bio Description and Business Overview
Table 86. Hile Bio Swine Vaccines Product
Table 87. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Hile Bio Sales Proportion of Swine Vaccines by Product in 2024
Table 89. Hile Bio Sales Proportion of Swine Vaccines by Application in 2024
Table 90. Hile Bio Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 91. Hile Bio Recent Developments
Table 92. Chopper Biology Company Information
Table 93. Chopper Biology Description and Business Overview
Table 94. Chopper Biology Swine Vaccines Product
Table 95. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. Chopper Biology Sales Proportion of Swine Vaccines by Product in 2024
Table 97. Chopper Biology Sales Proportion of Swine Vaccines by Application in 2024
Table 98. Chopper Biology Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 99. Chopper Biology Recent Developments
Table 100. WINSUN Company Information
Table 101. WINSUN Description and Business Overview
Table 102. WINSUN Swine Vaccines Product
Table 103. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 104. WINSUN Sales Proportion of Swine Vaccines by Product in 2024
Table 105. WINSUN Sales Proportion of Swine Vaccines by Application in 2024
Table 106. WINSUN Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 107. WINSUN Recent Developments
Table 108. Hipra Company Information
Table 109. Hipra Description and Business Overview
Table 110. Hipra Swine Vaccines Product
Table 111. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 112. Hipra Sales Proportion of Swine Vaccines by Product in 2024
Table 113. Hipra Sales Proportion of Swine Vaccines by Application in 2024
Table 114. Hipra Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 115. Hipra Recent Developments
Table 116. Ringpu Biology Company Information
Table 117. Ringpu Biology Description and Business Overview
Table 118. Ringpu Biology Swine Vaccines Product
Table 119. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Ringpu Biology Sales Proportion of Swine Vaccines by Product in 2024
Table 121. Ringpu Biology Sales Proportion of Swine Vaccines by Application in 2024
Table 122. Ringpu Biology Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 123. Ringpu Biology Recent Developments
Table 124. ChengDu Tecbond Company Information
Table 125. ChengDu Tecbond Description and Business Overview
Table 126. ChengDu Tecbond Swine Vaccines Product
Table 127. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. ChengDu Tecbond Sales Proportion of Swine Vaccines by Product in 2024
Table 129. ChengDu Tecbond Sales Proportion of Swine Vaccines by Application in 2024
Table 130. ChengDu Tecbond Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 131. ChengDu Tecbond Recent Developments
Table 132. DHN Company Information
Table 133. DHN Description and Business Overview
Table 134. DHN Swine Vaccines Product
Table 135. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. DHN Sales Proportion of Swine Vaccines by Product in 2024
Table 137. DHN Sales Proportion of Swine Vaccines by Application in 2024
Table 138. DHN Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 139. DHN Recent Developments
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Swine Vaccines Product
Table 143. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 144. CAVAC Sales Proportion of Swine Vaccines by Product in 2024
Table 145. CAVAC Sales Proportion of Swine Vaccines by Application in 2024
Table 146. CAVAC Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 147. CAVAC Recent Developments
Table 148. Virbac Company Information
Table 149. Virbac Description and Business Overview
Table 150. Virbac Swine Vaccines Product
Table 151. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 152. Virbac Sales Proportion of Swine Vaccines by Product in 2024
Table 153. Virbac Sales Proportion of Swine Vaccines by Application in 2024
Table 154. Virbac Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 155. Virbac Recent Developments
Table 156. HVRI Company Information
Table 157. HVRI Description and Business Overview
Table 158. HVRI Swine Vaccines Product
Table 159. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. HVRI Sales Proportion of Swine Vaccines by Product in 2024
Table 161. HVRI Sales Proportion of Swine Vaccines by Application in 2024
Table 162. HVRI Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 163. HVRI Recent Developments
Table 164. Bioveta Company Information
Table 165. Bioveta Description and Business Overview
Table 166. Bioveta Swine Vaccines Product
Table 167. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Bioveta Sales Proportion of Swine Vaccines by Product in 2024
Table 169. Bioveta Sales Proportion of Swine Vaccines by Application in 2024
Table 170. Bioveta Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 171. Bioveta Recent Developments
Table 172. North America Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 173. North America Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 174. North America Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 175. North America Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 176. North America Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 177. North America Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 178. Asia-Pacific Swine Vaccines Sales by Region (2020-2025) & (M Doses)
Table 179. Asia-Pacific Swine Vaccines Sales by Region (2026-2031) & (M Doses)
Table 180. Asia-Pacific Swine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 181. Asia-Pacific Swine Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 182. Asia-Pacific Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 183. Asia-Pacific Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 184. Europe Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 185. Europe Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 186. Europe Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 187. Europe Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 188. Europe Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 189. Europe Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 190. Latin America Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 191. Latin America Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 192. Latin America Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 193. Latin America Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 194. Latin America Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 195. Latin America Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 196. Middle East and Africa Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 197. Middle East and Africa Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 198. Middle East and Africa Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 199. Middle East and Africa Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 200. Middle East and Africa Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 201. Middle East and Africa Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 202. Swine Vaccines Key Raw Materials, Industry Status and Trend
Table 203. Swine Vaccines Key Raw Materials and Upstream Suppliers
Table 204. Swine Vaccines Clients Status and Trend
Table 205. Swine Vaccines Typical Clients
Table 206. Swine Vaccines Distributors
Table 207. Swine Vaccines Market Trends
Table 208. Swine Vaccines Market Drivers
Table 209. Swine Vaccines Market Challenges
Table 210. Swine Vaccines Market Restraints
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
Table 214. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Swine Vaccines Product Picture
Figure 2. Global Swine Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Swine Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Swine Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Swine Vaccines Sales Market Share by Application in 2024 & 2031
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Swine Vaccines Report Years Considered
Figure 14. Global Swine Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Swine Vaccines Market Size 2020-2031 (US$ Million)
Figure 16. Global Swine Vaccines Sales 2020-2031 (M Doses)
Figure 17. Global Swine Vaccines Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Swine Vaccines Revenue Market Share by Region (2020-2031)
Figure 19. Global Swine Vaccines Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Swine Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Swine Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/K Doses)
Figure 22. Global Swine Vaccines Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Swine Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Swine Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/K Doses)
Figure 25. CSF Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 26. FMD Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 27. Porcine Circovirus Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 28. PRRS Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 29. Others of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 30. Global Swine Vaccines Sales Share by Manufacturer in 2024
Figure 31. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. CSF Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 33. FMD Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 34. Porcine Circovirus Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 35. PRRS Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 36. Others Market Sales Proportion by Manufacturer in 2024
Figure 37. North America Swine Vaccines Revenue 2020-2031 (US$ Million)
Figure 38. North America Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 39. North America Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 40. Asia-Pacific Swine Vaccines Revenue 2020-2031 (US$ Million)
Figure 41. Asia-Pacific Swine Vaccines Sales Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Swine Vaccines Revenue Market Share by Region (2020-2031)
Figure 43. Asia-Pacific Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 44. Asia-Pacific Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 45. Europe Swine Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Europe Swine Vaccines Sales Market Share by Country (2020-2031)
Figure 47. Europe Swine Vaccines Revenue Market Share by Country (2020-2031)
Figure 48. Europe Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 49. Europe Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 50. Latin America Swine Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Latin America Swine Vaccines Sales Market Share by Country (2020-2031)
Figure 52. Latin America Swine Vaccines Revenue Market Share by Country (2020-2025)
Figure 53. Latin America Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 54. Latin America Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 55. Middle East and Africa Swine Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Middle East and Africa Swine Vaccines Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Swine Vaccines Revenue Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Middle East and Africa Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Swine Vaccines Supply Chain (Upstream and Downstream Market)
Figure 61. Global Production Market Share of Swine Vaccines Raw Materials by Region in 2024
Figure 62. Swine Vaccines Distribution Channels
Figure 63. Global Swine Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 64. Global Swine Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Swine Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Swine Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Swine Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Swine Vaccines Sales by Region (2020-2025) & (M Doses)
Table 5. Global Swine Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Swine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Swine Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Swine Vaccines Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Swine Vaccines Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Swine Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Swine Vaccines Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Swine Vaccines Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Swine Vaccines Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Swine Vaccines Sales Share by Manufacturer (2020-2025)
Table 18. Swine Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Swine Vaccines Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Swine Vaccines Price (2020-2025) & (USD/K Doses)
Table 21. Ranking of Global Top Swine Vaccines Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Swine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Swine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Vaccines as of 2024)
Table 24. Swine Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Swine Vaccines Market
Table 26. Manufacturers Swine Vaccines Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Merck Company Information
Table 29. Merck Description and Business Overview
Table 30. Merck Swine Vaccines Product
Table 31. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 32. Merck Sales Proportion of Swine Vaccines by Product in 2024
Table 33. Merck Sales Proportion of Swine Vaccines by Application in 2024
Table 34. Merck Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 35. Merck Recent Developments
Table 36. Boehringer Ingelheim Company Information
Table 37. Boehringer Ingelheim Description and Business Overview
Table 38. Boehringer Ingelheim Swine Vaccines Product
Table 39. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 40. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Product in 2024
Table 41. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Application in 2024
Table 42. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 43. Boehringer Ingelheim Recent Developments
Table 44. Jinyu Bio-Technology Company Information
Table 45. Jinyu Bio-Technology Description and Business Overview
Table 46. Jinyu Bio-Technology Swine Vaccines Product
Table 47. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 48. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Product in 2024
Table 49. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Application in 2024
Table 50. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 51. Jinyu Bio-Technology Recent Developments
Table 52. CAHIC Company Information
Table 53. CAHIC Description and Business Overview
Table 54. CAHIC Swine Vaccines Product
Table 55. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 56. CAHIC Sales Proportion of Swine Vaccines by Product in 2024
Table 57. CAHIC Sales Proportion of Swine Vaccines by Application in 2024
Table 58. CAHIC Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 59. CAHIC Recent Developments
Table 60. Tecon Company Information
Table 61. Tecon Description and Business Overview
Table 62. Tecon Swine Vaccines Product
Table 63. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 64. Tecon Sales Proportion of Swine Vaccines by Product in 2024
Table 65. Tecon Sales Proportion of Swine Vaccines by Application in 2024
Table 66. Tecon Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 67. Tecon Recent Developments
Table 68. Zoetis Company Information
Table 69. Zoetis Description and Business Overview
Table 70. Zoetis Swine Vaccines Product
Table 71. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 72. Zoetis Sales Proportion of Swine Vaccines by Product in 2024
Table 73. Zoetis Sales Proportion of Swine Vaccines by Application in 2024
Table 74. Zoetis Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 75. Zoetis Recent Developments
Table 76. Ceva Company Information
Table 77. Ceva Description and Business Overview
Table 78. Ceva Swine Vaccines Product
Table 79. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Ceva Sales Proportion of Swine Vaccines by Product in 2024
Table 81. Ceva Sales Proportion of Swine Vaccines by Application in 2024
Table 82. Ceva Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 83. Ceva Recent Developments
Table 84. Hile Bio Company Information
Table 85. Hile Bio Description and Business Overview
Table 86. Hile Bio Swine Vaccines Product
Table 87. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Hile Bio Sales Proportion of Swine Vaccines by Product in 2024
Table 89. Hile Bio Sales Proportion of Swine Vaccines by Application in 2024
Table 90. Hile Bio Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 91. Hile Bio Recent Developments
Table 92. Chopper Biology Company Information
Table 93. Chopper Biology Description and Business Overview
Table 94. Chopper Biology Swine Vaccines Product
Table 95. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. Chopper Biology Sales Proportion of Swine Vaccines by Product in 2024
Table 97. Chopper Biology Sales Proportion of Swine Vaccines by Application in 2024
Table 98. Chopper Biology Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 99. Chopper Biology Recent Developments
Table 100. WINSUN Company Information
Table 101. WINSUN Description and Business Overview
Table 102. WINSUN Swine Vaccines Product
Table 103. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 104. WINSUN Sales Proportion of Swine Vaccines by Product in 2024
Table 105. WINSUN Sales Proportion of Swine Vaccines by Application in 2024
Table 106. WINSUN Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 107. WINSUN Recent Developments
Table 108. Hipra Company Information
Table 109. Hipra Description and Business Overview
Table 110. Hipra Swine Vaccines Product
Table 111. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 112. Hipra Sales Proportion of Swine Vaccines by Product in 2024
Table 113. Hipra Sales Proportion of Swine Vaccines by Application in 2024
Table 114. Hipra Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 115. Hipra Recent Developments
Table 116. Ringpu Biology Company Information
Table 117. Ringpu Biology Description and Business Overview
Table 118. Ringpu Biology Swine Vaccines Product
Table 119. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Ringpu Biology Sales Proportion of Swine Vaccines by Product in 2024
Table 121. Ringpu Biology Sales Proportion of Swine Vaccines by Application in 2024
Table 122. Ringpu Biology Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 123. Ringpu Biology Recent Developments
Table 124. ChengDu Tecbond Company Information
Table 125. ChengDu Tecbond Description and Business Overview
Table 126. ChengDu Tecbond Swine Vaccines Product
Table 127. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. ChengDu Tecbond Sales Proportion of Swine Vaccines by Product in 2024
Table 129. ChengDu Tecbond Sales Proportion of Swine Vaccines by Application in 2024
Table 130. ChengDu Tecbond Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 131. ChengDu Tecbond Recent Developments
Table 132. DHN Company Information
Table 133. DHN Description and Business Overview
Table 134. DHN Swine Vaccines Product
Table 135. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. DHN Sales Proportion of Swine Vaccines by Product in 2024
Table 137. DHN Sales Proportion of Swine Vaccines by Application in 2024
Table 138. DHN Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 139. DHN Recent Developments
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Swine Vaccines Product
Table 143. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 144. CAVAC Sales Proportion of Swine Vaccines by Product in 2024
Table 145. CAVAC Sales Proportion of Swine Vaccines by Application in 2024
Table 146. CAVAC Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 147. CAVAC Recent Developments
Table 148. Virbac Company Information
Table 149. Virbac Description and Business Overview
Table 150. Virbac Swine Vaccines Product
Table 151. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 152. Virbac Sales Proportion of Swine Vaccines by Product in 2024
Table 153. Virbac Sales Proportion of Swine Vaccines by Application in 2024
Table 154. Virbac Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 155. Virbac Recent Developments
Table 156. HVRI Company Information
Table 157. HVRI Description and Business Overview
Table 158. HVRI Swine Vaccines Product
Table 159. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. HVRI Sales Proportion of Swine Vaccines by Product in 2024
Table 161. HVRI Sales Proportion of Swine Vaccines by Application in 2024
Table 162. HVRI Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 163. HVRI Recent Developments
Table 164. Bioveta Company Information
Table 165. Bioveta Description and Business Overview
Table 166. Bioveta Swine Vaccines Product
Table 167. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Bioveta Sales Proportion of Swine Vaccines by Product in 2024
Table 169. Bioveta Sales Proportion of Swine Vaccines by Application in 2024
Table 170. Bioveta Sales Proportion of Swine Vaccines by Geographic Area in 2024
Table 171. Bioveta Recent Developments
Table 172. North America Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 173. North America Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 174. North America Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 175. North America Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 176. North America Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 177. North America Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 178. Asia-Pacific Swine Vaccines Sales by Region (2020-2025) & (M Doses)
Table 179. Asia-Pacific Swine Vaccines Sales by Region (2026-2031) & (M Doses)
Table 180. Asia-Pacific Swine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 181. Asia-Pacific Swine Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 182. Asia-Pacific Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 183. Asia-Pacific Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 184. Europe Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 185. Europe Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 186. Europe Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 187. Europe Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 188. Europe Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 189. Europe Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 190. Latin America Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 191. Latin America Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 192. Latin America Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 193. Latin America Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 194. Latin America Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 195. Latin America Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 196. Middle East and Africa Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 197. Middle East and Africa Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 198. Middle East and Africa Swine Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 199. Middle East and Africa Swine Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 200. Middle East and Africa Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 201. Middle East and Africa Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 202. Swine Vaccines Key Raw Materials, Industry Status and Trend
Table 203. Swine Vaccines Key Raw Materials and Upstream Suppliers
Table 204. Swine Vaccines Clients Status and Trend
Table 205. Swine Vaccines Typical Clients
Table 206. Swine Vaccines Distributors
Table 207. Swine Vaccines Market Trends
Table 208. Swine Vaccines Market Drivers
Table 209. Swine Vaccines Market Challenges
Table 210. Swine Vaccines Market Restraints
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
Table 214. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Swine Vaccines Product Picture
Figure 2. Global Swine Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Swine Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Swine Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Swine Vaccines Sales Market Share by Application in 2024 & 2031
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Swine Vaccines Report Years Considered
Figure 14. Global Swine Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Swine Vaccines Market Size 2020-2031 (US$ Million)
Figure 16. Global Swine Vaccines Sales 2020-2031 (M Doses)
Figure 17. Global Swine Vaccines Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Swine Vaccines Revenue Market Share by Region (2020-2031)
Figure 19. Global Swine Vaccines Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Swine Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Swine Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/K Doses)
Figure 22. Global Swine Vaccines Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Swine Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Swine Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/K Doses)
Figure 25. CSF Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 26. FMD Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 27. Porcine Circovirus Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 28. PRRS Vaccines of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 29. Others of Swine Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 30. Global Swine Vaccines Sales Share by Manufacturer in 2024
Figure 31. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. CSF Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 33. FMD Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 34. Porcine Circovirus Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 35. PRRS Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 36. Others Market Sales Proportion by Manufacturer in 2024
Figure 37. North America Swine Vaccines Revenue 2020-2031 (US$ Million)
Figure 38. North America Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 39. North America Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 40. Asia-Pacific Swine Vaccines Revenue 2020-2031 (US$ Million)
Figure 41. Asia-Pacific Swine Vaccines Sales Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Swine Vaccines Revenue Market Share by Region (2020-2031)
Figure 43. Asia-Pacific Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 44. Asia-Pacific Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 45. Europe Swine Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Europe Swine Vaccines Sales Market Share by Country (2020-2031)
Figure 47. Europe Swine Vaccines Revenue Market Share by Country (2020-2031)
Figure 48. Europe Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 49. Europe Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 50. Latin America Swine Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Latin America Swine Vaccines Sales Market Share by Country (2020-2031)
Figure 52. Latin America Swine Vaccines Revenue Market Share by Country (2020-2025)
Figure 53. Latin America Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 54. Latin America Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 55. Middle East and Africa Swine Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Middle East and Africa Swine Vaccines Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Swine Vaccines Revenue Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Swine Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Middle East and Africa Swine Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Swine Vaccines Supply Chain (Upstream and Downstream Market)
Figure 61. Global Production Market Share of Swine Vaccines Raw Materials by Region in 2024
Figure 62. Swine Vaccines Distribution Channels
Figure 63. Global Swine Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 64. Global Swine Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232